Skip to main content
Signal8

Rangwala Reshma

SEC insider (Form 3/4/5 filer). CIK 0001825322. EVP & Chief Medical Officer at Karyopharm Therapeutics Inc. (KPTI). 11 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in NEWTON, MA.

Companies Rangwala Reshma has filed insider reports for

  • Karyopharm Therapeutics Inc. (KPTI): Officer, EVP & Chief Medical Officer
Rangwala Reshma profile photo

Rangwala Reshma

CIK: 0001825322

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (54.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (45.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Karyopharm Therapeutics Inc. logo
KPTI

Karyopharm Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    May 14, 2026
    Sale
    Direct
    408 shares at avg. $9.50$4K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    May 13, 2026
    Award
    Direct
    947 shares-
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Apr 21, 2026
    Sale
    Direct
    449 shares at avg. $8.94$4K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Mar 2, 2026
    Sale
    Direct
    5.1K shares at avg. $9.41$48K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Jan 31, 2026
    Award
    Direct
    32.4K shares-
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Sep 15, 2025
    Sale
    Direct
    408 shares at avg. $6.43$3K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Sep 12, 2025
    Award
    Direct
    945 shares-
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Apr 23, 2025
    Sale
    Direct
    419 shares at avg. $6.17$3K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Mar 4, 2025
    Sale
    Direct
    3.6K shares at avg. $6.29$23K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Feb 28, 2025
    Award
    Direct
    4.6K shares-

1-10 of 11